dbACP: A Comprehensive Database of Anti-Cancer Peptides

6 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp07197 EEK GLLELLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.10 ± 0.14 µM
dbacp07198 EEK GLLELLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.08 ± 0.18 µM
dbacp07199 EEK GLLELLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 32.88 ± 4.07 µM
dbacp07236 d-EEK GllellelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 0.29 ± 0.01 µM
dbacp07237 d-EEK GllellelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 0.29 ± 0.01 µM
dbacp07238 d-EEK GllellelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 4.78 ± 0.02 µM